EPISODE · Jun 5, 2025 · 35 MIN
Corporate reputation in the age of GLP-1
from Ipsos in the UK Podcast · host Ipsos in the UK
Listen to Thomas Fife-Schaw and Nick Gabery Adams, former VP of Corporate Brand at Novo Nordisk, discuss how GLP-1 medications like Ozempic and Wegovy are changing the pharmaceutical landscape. From reshaping corporate reputation, to boosting investor confidence, discover how these drugs are rewriting the rules for pharma brands.
Embed this episode
NOW PLAYING
Corporate reputation in the age of GLP-1
0:00
35:33
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Ipsos in the UK Podcast?
This episode is 35 minutes long.
When was this Ipsos in the UK Podcast episode published?
This episode was published on June 5, 2025.
Can I download this Ipsos in the UK Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!